Medline Inc. Class A Common Stock vs Medtronic PLC — how do they compare? Medline Inc. Class A Common Stock trades at $35.75 (market cap $31.10B), while Medtronic PLC trades at $87.86 (market cap $109.38B). The key difference: Medtronic PLC is far larger — about 3.5× Medline Inc. Class A Common Stock's market cap, and Medtronic PLC pays a 3.37% dividend while Medline Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Medline Inc. Class A Common Stock for 0 Days and Medtronic PLC for 63 Days on average.
| MDLN | MDT | |
|---|---|---|
Market Cap | $31.10B | $109.38B |
Volume | 4,471,639 | 55,890,185 |
Sector | Health | Health |
52-Week High | $49.99 | $105.35 |
52-Week Low | $31.64 | $73.75 |
Typical Hold Time | 0 Days | 63 Days |
Enterprise Value | $41.07B | $128.71B |
Dividend Yield | — | 3.37% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Medtronic (MDT) trades at $87.75, up 0.76% on the day, with strong analyst support (60.78% buy ratings) and a $97.80 consensus price target suggesting 11.4% upside. The stock shows consistent earnings beats in recent quarters with Q3 2026 results pending, while technical indicators signal bearish momentum despite oversold RSI readings. Recent positive developments include FDA clearances for new medical technologies and a 49-year dividend growth streak with a current 3.2% yield.
MDT presents a compelling value opportunity with reasonable valuation multiples (P/E 21.06, P/S 2.93) and improving fundamentals, though technical weakness and competitive pressures warrant caution. The company's revenue growth acceleration to $33.54B in 2025 and strong cash flow generation support the dividend sustainability, while debt levels have increased to 31.11% of assets, representing a key monitoring point for investors.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Medline provides medical-surgical products and supply-chain solutions for healthcare providers. Its portfolio and distribution network serve hospitals, clinics, long-term care facilities, and other care settings.
Read more on MDLN →One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →